Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...
Some cases expand on earlier initiatives, like the Valsartan cases. The theory against these was launched from the Zantac ...
TipRanks on MSN2d
GSK downgraded to Hold from Buy at JefferiesJefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm ...
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback